Group 1 - The core product, the Tumi surgical robot, has surpassed 200 global commercial orders, covering nearly 50 countries and regions, with approximately 130 installations completed [1] - The increase in commercial orders and installations signifies the global recognition of Tumi's clinical value, demonstrating systematic certification of its safety, stability, and reliability [1] - In the nearly 50 countries covered, 12 have more than 5 orders, with strong growth in emerging markets like India (14 orders) and Brazil (over 10 orders), while developed markets like Spain and Australia are also experiencing rapid growth [1] Group 2 - Tumi is the first remote surgical robot system approved for commercial application, having received approvals in nearly 10 countries, including China, India, and Brazil, covering areas with nearly half of the global population [2] - Tumi has completed nearly 800 remote surgeries across over 20 countries, maintaining a 100% success rate [2]